The ANOVA analysis of the percentage of apoptotic DCs in the total number of DCs infiltrating the primary melanomas revealed significant differences in the apoptotic rates in between the different treatment groups (P=0.001).
To further investigate the primary cause of significant differences in CRISPR elements between periodontally diseased patients and healthy people, we conducted F-test to compare the abundance variation of each DRs and spacers.
However, regarding the two-surface restorations in the primary dentition, statistically significant differences between the four dentists appeared (log-rank statistic 11.7, df = 3, p = 0.009).
For the insulin glargine arm of the study, we observed a statistically nonsignificant reduction in CIMT progression for the primary outcome and significant differences, favoring insulin glargine therapy for the secondary CIMT outcomes.
Forest plots for primary outcomes with significant differences in any of the meta-analyses are shown as supplementary figure 2, with the exception of those for birth weight and any neonatal hypoglycaemia, which are displayed in figures 1 and 2. I=Heterogeneity.
An independent t-test analysis was carried out for the primary independent variable (timing of administration of antibiotics) and primary outcome (mortality) for significant differences between the groups.
Regional imbalance and disparities According to the Multi Indicators Cluster Survey 3 (MICS 3), while 88.5 per cent of children of primary school entry age (6 years) in Lebanon attend first grade of primary school, there are significant differences between regions.
Metastases to different sites (from the same primary tumor) frequently showed significant differences in histology and gene expression [ 8].
In terms of number of leaves and number of primaries, there were no significant differences (p > 0.05) due to different irrigation levels (Fig. 4c, d).
The primary analyses revealed no significant differences between guanfacine and placebo treatment; however, exploratory non-parametric statistics revealed some significant and some trend differences between guanfacine and placebo on spatial working memory test performance and CPT reaction time in those subjects treated with atypical neuroleptics.
